Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier organic anion transporter family member 2A1 (SLCO2A1), commonly known as the prostaglandin transporter (PGT), is a 12-membrane-spanning protein primarily responsible for the transport and cellular uptake of prostaglandins and certain thromboxanes across mammalian cell membranes. It plays essential roles in regulating prostaglandin concentrations within various tissues, thereby modulating many physiological processes including vascular tone, inflammation, gastric protection, renal function, reproductive events, and fever response. SLCO2A1 dysfunction or mutations are implicated in several rare diseases, especially primary hypertrophic osteoarthropathy and chronic enteropathies. The transporter acts as both importer and exporter in a tissue-dependent context, mediating clearance of prostaglandins and facilitating their movement between tissue compartments.
Drugs that block or modulate SLCO2A1 function may alter prostaglandin uptake and tissue clearance, impacting prostaglandin signaling NSAIDs decrease the substrate pool (prostaglandins) for SLCO2A1-mediated transport
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier organic anion transporter family member 2A1 (SLCO2A1).